3 Year Absolute Returns
45.45% ↑
NAV (₹) on 20 Aug 2026
24.13
1 Day NAV Change
0.00%
Risk Level
Very High Risk
Rating
-
Aditya Birla Sun Life Pharma & Healthcare Fund is a Equity mutual fund categorized under Sector, offered by Aditya Birla Sun Life AMC Limited. Launched on 20 Jun 2019, investors can start with a ... Read more
AUM
₹ 1,073.85 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 73.53% |
| Hospitals & Medical Services | 21.09% |
| Treps/Reverse Repo | 2.30% |
| Chemicals - Speciality | 1.36% |
| Insurance Distributor | 0.87% |
| Chemicals - Organic - Benzene Based | 0.78% |
| Net Receivables/(Payables) | 0.09% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Torrent Pharmaceuticals Ltd. | 9.94% | ₹ 106.69 | Pharmaceuticals |
| Sun Pharmaceutical Industries Ltd. | 9.75% | ₹ 104.72 | Pharmaceuticals |
| Apollo Hospitals Enterprise Ltd. | 7.08% | ₹ 76.08 | Hospitals & Medical Services |
| Cipla Ltd. | 4.56% | ₹ 48.92 | Pharmaceuticals |
| Aurobindo Pharma Ltd. | 4.29% | ₹ 46.02 | Pharmaceuticals |
| Ajanta Pharma Ltd. | 4.17% | ₹ 44.81 | Pharmaceuticals |
| Sai Life Sciences Ltd. | 3.89% | ₹ 41.72 | Pharmaceuticals |
| Mankind Pharma Ltd. | 3.58% | ₹ 38.42 | Pharmaceuticals |
| Lupin Ltd. | 3.51% | ₹ 37.73 | Pharmaceuticals |
| Abbott India Ltd. | 3.35% | ₹ 35.95 | Pharmaceuticals |
| Emcure Pharmaceuticals Ltd. | 3.24% | ₹ 34.84 | Pharmaceuticals |
| Fortis Healthcare Ltd. | 2.98% | ₹ 32.04 | Hospitals & Medical Services |
| IPCA Laboratories Ltd. | 2.47% | ₹ 26.49 | Pharmaceuticals |
| Gland Pharma Ltd. | 2.34% | ₹ 25.16 | Pharmaceuticals |
| Shilpa Medicare Ltd. | 2.32% | ₹ 24.88 | Pharmaceuticals |
| TREPS | 2.30% | ₹ 24.67 | Others |
| Corona Remedies Ltd. | 2.29% | ₹ 24.55 | Pharmaceuticals |
| Procter & Gamble Health Ltd. | 2.16% | ₹ 23.24 | Pharmaceuticals |
| Dr. Lal Path labs Ltd. | 2.12% | ₹ 22.82 | Hospitals & Medical Services |
| Jupiter Life Line Hospitals Ltd. | 2.03% | ₹ 21.78 | Hospitals & Medical Services |
| Divi's Laboratories Ltd. | 1.95% | ₹ 20.95 | Pharmaceuticals |
| Thyrocare Technologies Ltd. | 1.91% | ₹ 20.53 | Hospitals & Medical Services |
| Alkem Laboratories Ltd. | 1.88% | ₹ 20.15 | Pharmaceuticals |
| Metropolis Healthcare Ltd. | 1.59% | ₹ 17.10 | Hospitals & Medical Services |
| Sanofi Consumer Healthcare India Ltd. | 1.36% | ₹ 14.55 | Chemicals - Speciality |
| Pfizer Ltd. | 1.26% | ₹ 13.53 | Pharmaceuticals |
| Biocon Ltd. | 1.26% | ₹ 13.50 | Pharmaceuticals |
| Piramal Pharma Ltd. | 1.16% | ₹ 12.48 | Pharmaceuticals |
| Anthem Biosciences Ltd. | 1.07% | ₹ 11.47 | Pharmaceuticals |
| Dr. Reddy's Laboratories Ltd. | 1.06% | ₹ 11.36 | Pharmaceuticals |
| Vijaya Diagnostic Centre Ltd. | 0.98% | ₹ 10.51 | Hospitals & Medical Services |
| Manipal Health Enterprises Ltd A | 0.89% | ₹ 9.58 | Hospitals & Medical Services |
| Medi Assist Healthcare Services Ltd. | 0.87% | ₹ 9.36 | Insurance Distributor |
| Glaxosmithkline Pharmaceuticals Ltd. | 0.80% | ₹ 8.60 | Pharmaceuticals |
| Suraksha Diagnostic Ltd. | 0.79% | ₹ 8.44 | Hospitals & Medical Services |
| Vinati Organics Ltd. | 0.78% | ₹ 8.35 | Chemicals - Organic - Benzene Based |
| Max Healthcare Institute Ltd. | 0.72% | ₹ 7.69 | Hospitals & Medical Services |
| Syngene International Ltd. | 0.68% | ₹ 7.30 | Pharmaceuticals |
| Jubilant Pharmova Ltd. | 0.55% | ₹ 5.90 | Pharmaceuticals |
| Net Receivable / Payable | 0.09% | ₹ 0.96 | Others |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 10.38% | 8.45% | 1.40% | 13.30% |
| Category returns | 4.98% | 7.41% | 6.99% | 24.15% |
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.39 | 148.38% | 303.80% | 0.00% | ₹947 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.39 | 148.38% | 303.80% | 0.00% | ₹947 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.39 | 148.38% | 303.80% | 0.00% | ₹947 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹34 | 145.04% | 287.42% | 0.00% | ₹947 | 2.53% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹34 | 145.04% | 287.42% | 0.00% | ₹947 | 2.53% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹34 | 145.04% | 287.42% | 0.00% | ₹947 | 2.53% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹31.60 | 32.71% | 184.15% | 0.00% | ₹10,709 | 0.90% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹31.60 | 32.71% | 184.15% | 0.00% | ₹10,709 | 0.90% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹31.60 | 32.71% | 184.15% | 0.00% | ₹10,709 | 0.90% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹30.49 | 31.40% | 174.92% | 0.00% | ₹10,709 | 1.79% |
Very High
|
What is the current NAV of Aditya Birla Sun Life Pharma & Healthcare Fund Regular IDCW?
What is the fund size (AUM) of Aditya Birla Sun Life Pharma & Healthcare Fund Regular IDCW?
What are the historical returns of Aditya Birla Sun Life Pharma & Healthcare Fund Regular IDCW?
What is the risk level of Aditya Birla Sun Life Pharma & Healthcare Fund Regular IDCW?
What is the minimum investment amount for Aditya Birla Sun Life Pharma & Healthcare Fund Regular IDCW?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article